Esophageal cancer: Year of the Zebra

Last updated: May 01, 2023

Esophageal cancer: Year of the Zebra

Gastrointestinal

Gastrointestinal

Esophagitis: Clinical sciences
Esophageal disorders: Pathology review
Esophageal cancer: Clinical sciences
Esophageal cancer
Esophageal perforation: Clinical sciences
Esophageal cancer: Year of the Zebra
Eosinophilic esophagitis (NORD)
Esophageal disorders: Clinical
Gastroesophageal reflux disease: Clinical sciences
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Approach to melena and hematemesis: Clinical sciences
Esophagitis: Clinical
Achalasia: Year of the Zebra
Gastroesophageal reflux disease (GERD)
Esophageal web
Barrett esophagus
Diffuse esophageal spasm
Portal hypertension
Mallory-Weiss syndrome: Clinical sciences
Gastrointestinal bleeding: Pathology review
Gastroesophageal varices: Clinical sciences
Cirrhosis: Clinical sciences
Gastroesophageal reflux disease (GERD): Clinical
Gastric cancer: Clinical sciences
Peptic ulcer disease: Clinical sciences
Pancreatic cancer
Pancreatitis: Pathology review
Chronic pancreatitis
Acute pancreatitis
Pancreatic neuroendocrine neoplasms
Chronic pancreatitis: Clinical sciences
Pancreatic cancer: Clinical sciences
Acute pancreatitis: Clinical sciences
Zollinger-Ellison syndrome
Multiple endocrine neoplasia: Clinical sciences
Cystic fibrosis
Stress ulcers: Clinical sciences
Ulcerative colitis
Inflammatory bowel disease (ulcerative colitis): Clinical sciences
Inflammatory bowel disease: Pathology review
Gallbladder carcinoma
Gallbladder disorders: Pathology review
Acute cholecystitis
Gallstones
Gallstone ileus
Cholecystitis: Clinical sciences
Biliary colic
Chronic cholecystitis
Approach to upper abdominal pain: Clinical sciences
Choledocholithiasis and cholangitis: Clinical sciences
Ascending cholangitis
Cholestatic liver disease
Jaundice: Pathology review
Jaundice
Approach to jaundice (unconjugated hyperbilirubinemia): Clinical sciences
Approach to jaundice (conjugated hyperbilirubinemia): Clinical sciences
Jaundice: Clinical
Neonatal jaundice: Clinical
Hepatitis A and Hepatitis E virus
Hepatitis B and Hepatitis D virus
Viral hepatitis
Hepatitis C virus
Viral hepatitis: Pathology review
Hepatitis C: Clinical sciences
Hepatitis B: Clinical sciences
Hepatitis A and E: Clinical sciences
Alcohol-induced hepatitis: Clinical sciences
Hepatic encephalopathy
Viral hepatitis: Clinical
Hepatocellular carcinoma
Cirrhosis: Pathology review
Colorectal cancer
Ischemic colitis: Clinical sciences
Colorectal polyps
Colorectal polyps and cancer: Pathology review
Colorectal cancer: Clinical sciences
Approach to constipation: Clinical sciences
Approach to hematochezia: Clinical sciences
Diverticulitis: Clinical sciences
Large bowel obstruction: Clinical sciences
Fecal impaction: Clinical sciences
Diverticular disease: Pathology review
Small bowel obstruction: Clinical sciences
Clostridium difficile (Pseudomembranous colitis)
Inflammatory bowel disease (Crohn disease): Clinical sciences
Diverticulosis and diverticulitis
Ileus: Clinical sciences
Familial adenomatous polyposis

Transcript

Watch video only

Esophageal cancer is when malignant or cancerous cells arise in the esophagus. This cancer can appear in any segment of the esophagus and it’s further classified into squamous cell carcinoma and adenocarcinoma - depending on the type of cells it originates from. Squamous cell carcinoma, as you can tell by its name, arises from squamous epithelium. On the other hand, adeno- means gland. So, adenocarcinoma arises from columnar glandular epithelium. Esophageal cancer is generally considered a poor prognosis cancer, because it doesn't cause symptoms until later stages.

The esophagus is a long tube going from the pharynx to the stomach, and it’s connected to the pharynx through the upper esophageal sphincter, and to the stomach through the lower esophageal sphincter. Both relax during swallowing to allow the passage of food or liquids. Additionally, the lower esophageal sphincter is tightly closed between meals to prevent acid reflux. Now, the esophageal wall has four layers - from the outside in, these are the adventitia; the muscular layer; the submucosa and the mucosa. The mucosa comes into direct contact with food, and it protects the esophageal wall from friction. The mucosa also has three layers of its own: a layer made of stratified squamous epithelium; a layer of connective tissue, called the lamina propria; and a layer of muscle cells, called the muscularis mucosae. Finally, at the lower esophageal sphincter, the squamous epithelium joins the columnar gastric epithelium to form the gastroesophageal junction.

Now, squamous cell carcinoma is the most common type of esophageal cancer worldwide, and it originates in the squamous epithelium of the esophagus, most often in the upper two thirds. When this epithelium is repeatedly exposed to risk factors like alcoholcigarette smoke, or hot fluids, it gets damaged, so the squamous cells divide to replace the old damaged cells. With each division, there is a risk that a mutation can occur in the genes that are in charge of the cell cycle and cell division. Mutations can occur in tumor suppressor genes, which normally code for proteins that stop the cell cycle or promote apoptosis - so they’re the cell cycle’s very own brake pedal. Or they can occur in proto-oncogenes, which normally code for proteins that promote the cell cycle - so they’re the cell cycle’s accelerator pedal. When this happens, squamous cells start dividing uncontrollably, and more mutations accumulate with each division. So eventually, these mutations might make the cells malignant - meaning they gain the ability to invade neighboring tissues and spread to distant sites.

On the other hand, adenocarcinoma is the most common type of esophageal cancer in the United States of America, and it originates in the columnar glandular epithelium, most often in the lower third of the esophagus. Most frequently, adenocarcinoma develops as a consequence of gastroesophageal reflux disease, or GERD for short. With GERD, the lower esophageal sphincter is weaker than normal, and it allows acid from the stomach to go back up into the esophagus after meals. The presence of acid in the esophagus can lead to Barrett’s esophagus, which is when the squamous epithelium lining the esophagus is replaced by a columnar epithelium, similar to that of the intestines, that’s better adapted to withstand the acidity. This process is called intestinal metaplasia. Over time, just like with squamous cell carcinoma, mutations might accumulate in either tumor suppressor genes or proto-oncogenes that control the division of these metaplastic cells, ultimately resulting in a malignant tumor.

Risk factors for both squamous cell carcinoma and adenocarcinoma include smoking, age over 60 years, and achalasia - which is when the smooth muscle of the lower portion of the esophagus doesn’t work well, making it difficult for food to pass towards the stomach. Specific risk factors for squamous cell carcinoma include alcohol consumption, hot fluids and caustic strictures, which is the narrowing of the esophagus following ingestion of a caustic substance, like household bleach. Other predisposing conditions include Plummer-Vinson syndrome and palmoplantar keratoderma. Plummer-Vinson syndrome associates iron deficiency anemiaglossitis, or tongue inflammation; cheilosis, or inflammation and cracking of the corners of the mouth; and esophageal webs or rings, which are concentric extensions of normal esophageal wall into the esophageal lumen that can cause difficulty swallowing. Palmoplantar keratoderma is a rare disease in which thick patches of skin develop on the hands and feet. The strongest risk factor for adenocarcinoma, on the other hand, is chronic GERD and Barrett's esophagus. Obesity and being a genetically male individual also increase the risk of adenocarcinoma.